Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


28.05.2018

3 Aliment Pharmacol Ther
9 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gut
34 Inflamm Bowel Dis
2 J Crohns Colitis
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. VANDE CASTEELE N, Feagan BG, Vermeire S, Yassine M, et al
    Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease.
    Aliment Pharmacol Ther. 2018;47:229-237.
    PubMed     Text format     Abstract available

  2. BAR-YOSEPH H, Levhar N, Selinger L, Manor U, et al
    Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.
    Aliment Pharmacol Ther. 2018;47:212-218.
    PubMed     Text format     Abstract available

  3. NORDENVALL C, Olen O, Nilsson PJ, von Seth E, et al
    Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.
    Aliment Pharmacol Ther. 2018;47:238-245.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  4. NGUYEN VQ, Mays JL, Lang M, Wu Y, et al
    Knowledge Gaps in the Management of Postoperative Crohn's Disease: A US National Survey.
    Dig Dis Sci. 2018;63:53-60.
    PubMed     Text format     Abstract available

  5. OSAMURA A, Suzuki Y
    Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors.
    Dig Dis Sci. 2018;63:204-208.
    PubMed     Text format     Abstract available

  6. BENMASSAOUD A, Al-Taweel T, Sasson MS, Moza D, et al
    Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naive Crohn's Disease.
    Dig Dis Sci. 2018;63:1302-1310.
    PubMed     Text format     Abstract available

  7. COUGNOUX A, Movassaghi M, Picache JA, Iben JR, et al
    Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.
    Dig Dis Sci. 2018;63:870-880.
    PubMed     Text format     Abstract available

  8. NOBEL YR, Axelrad J, Lewis SK, Whittier S, et al
    Stool PCR for Gastrointestinal Pathogens in Patients With and Without Immune-Mediated Intestinal Diseases.
    Dig Dis Sci. 2018;63:996-1002.
    PubMed     Text format     Abstract available

  9. CICCONE F, Ciccone A, Di Ruscio M, Vernia F, et al
    IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature.
    Dig Dis Sci. 2018;63:1072-1086.
    PubMed     Text format    

  10. LING J, Buurman D, Ravikumara M, Mews C, et al
    Accelerated Step-Up Infliximab Use Is Associated with Sustained Primary Response in Pediatric Crohn's Disease.
    Dig Dis Sci. 2018;63:1003-1010.
    PubMed     Text format     Abstract available

  11. CHANDRADAS S, Khalili H, Ananthakrishnan A, Wayman C, et al
    Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis?
    Dig Dis Sci. 2018 May 19. pii: 10.1007/s10620-018-5108.
    PubMed     Text format     Abstract available

  12. ABRAHAM BP, Quigley EMM
    A Probiotic for Ulcerative Colitis: The Culture Wars Continue.
    Dig Dis Sci. 2018 May 21. pii: 10.1007/s10620-018-5097.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  13. DERIKX LAAP, de Jong ME, Hoentjen F
    Recommendations on rectal surveillance for colorectal cancer after subtotal colectomy in patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2018 May 17. doi: 10.1097/MEG.0000000000001171.
    PubMed     Text format     Abstract available


    Gut

  14. VILLUMSEN M, Aznar S, Pakkenberg B, Jess T, et al
    Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014.
    Gut. 2018 May 21. pii: gutjnl-2017-315666. doi: 10.1136/gutjnl-2017-315666.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  15. KHANNA R, Zou G, Feagan BG
    Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future Solutions.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999190. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. MOTTA JP, Allain T, Green-Harrison LE, Groves RA, et al
    Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4997020. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. DAI C, Jiang M, Sun MJ
    Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999019. doi: 10.1093.
    PubMed     Text format    

  18. MITCHELL NE, Harrison N, Junga Z, Singla M, et al
    Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999386. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. SHMIDT E, Kochhar G, Hartke J, Chilukuri P, et al
    Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999184. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. ROBERTS RL, Wallace MC, Seinen ML, van Bodegraven AA, et al
    Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996867. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. GORREPATI VS, Stuart A, Deiling S, Koltun W, et al
    Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999006. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. MADSEN KG, Pottegard A, Hallas J, Kjeldsen J, et al
    Treatment Failure of TNF-alpha Inhibitors in Obese Patients With Inflammatory Bowel Disease-A Cohort Study.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998912. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. ZHANG M, Merlin D
    Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999330. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. ABUTALEB A, Buchwald A, Chudy-Onwugaje K, Langenberg P, et al
    Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999387. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. COLOMBEL JF
    Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998802. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. MERKER AM, Riaz M, Friedman S, Allegretti JR, et al
    Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999337. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. LIGHTNER AL
    A Cell-Based Approach to the Treatment of Inflammatory Bowel Disease-Entering an Era of Regenerative Medicine.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999009. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. LI L, Huang S, Wang H, Chao K, et al
    Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996911. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. WEIMERS P, Halfvarson J, Sachs MC, Saunders-Pullman R, et al
    Inflammatory Bowel Disease and Parkinson's Disease: A Nationwide Swedish Cohort Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996912. doi: 10.1093.
    PubMed     Text format     Abstract available

  30. BARNES EL, Kochar B, Long MD, Pekow J, et al
    Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999440. doi: 10.1093.
    PubMed     Text format     Abstract available

  31. RESTELLINI S, Khanna R, Afif W
    Therapeutic Drug Monitoring With Ustekinumab and Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999007. doi: 10.1093.
    PubMed     Text format     Abstract available

  32. JIAN L, Anqi H, Gang L, Litian W, et al
    Food Exclusion Based on IgG Antibodies Alleviates Symptoms in Ulcerative Colitis: A Prospective Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996921. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. PENG K, Qian X, Huang Z, Lu J, et al
    Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999329. doi: 10.1093.
    PubMed     Text format     Abstract available

  34. NAVABI S, Gorrepati VS, Yadav S, Chintanaboina J, et al
    Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999008. doi: 10.1093.
    PubMed     Text format     Abstract available

  35. BOSCH S, van Gaal N, Zuurbier RP, Covington JA, et al
    Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999303. doi: 10.1093.
    PubMed     Text format     Abstract available

  36. SPAGNUOLO R, Dattilo V, D'Antona L, Cosco C, et al
    Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999450. doi: 10.1093.
    PubMed     Text format     Abstract available

  37. HARTMAN DJ, Binion DG, Regueiro MD, Miller C, et al
    Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998978. doi: 10.1093.
    PubMed     Text format     Abstract available

  38. YUNG DE, Horesh N, Lightner AL, Ben-Horin S, et al
    Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998839. doi: 10.1093.
    PubMed     Text format     Abstract available

  39. LIU R, Tang A, Wang X, Shen S, et al
    Assessment of Quality of Life in Chinese Patients With Inflammatory Bowel Disease and their Caregivers.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999056. doi: 10.1093.
    PubMed     Text format     Abstract available

  40. ZHENG C, Huang Y, Ye Z, Wang Y, et al
    Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20).
    Inflamm Bowel Dis. 2018 May 17. pii: 4999659. doi: 10.1093.
    PubMed     Text format     Abstract available

  41. DORREEN A, Heisler C, Jones J
    Treatment of Inflammatory Bowel Disease in the Older Patient.
    Inflamm Bowel Dis. 2018;24:1155-1166.
    PubMed     Text format     Abstract available

  42. AL-AMODI O, Jodeleit H, Beigel F, Wolf E, et al
    CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998980. doi: 10.1093.
    PubMed     Text format     Abstract available

  43. KOSLOWSKY B, Grisaru-Granovsky S, Livovsky DM, Milgrom Y, et al
    Pregnancy-Onset Inflammatory Bowel Disease: A Subtle Diagnosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998813. doi: 10.1093.
    PubMed     Text format     Abstract available

  44. KOPYLOV U, Verstockt B, Biedermann L, Sebastian S, et al
    Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999380. doi: 10.1093.
    PubMed     Text format     Abstract available

  45. DIBLEY L, Czuber-Dochan W, Woodward S, Wade T, et al
    Development and Psychometric Properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A New Tool to Measure Disease-Specific Distress.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999398. doi: 10.1093.
    PubMed     Text format     Abstract available

  46. HEMPERLY A, Sandborn WJ, Vande Casteele N
    Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998913. doi: 10.1093.
    PubMed     Text format     Abstract available

  47. SUH JH, Degagne E, Gleghorn EE, Setty M, et al
    Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.
    Inflamm Bowel Dis. 2018;24:1321-1334.
    PubMed     Text format     Abstract available

  48. SZETO W, van der Bent A, Petty CR, Reich J, et al
    Use of Social Media for Health-Related Tasks by Adolescents With Inflammatory Bowel Disease: A Step in the Pathway of Transition.
    Inflamm Bowel Dis. 2018;24:1114-1122.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  49. BELVIS JIMENEZ M, Maldonado Perez B, Arguelles-Arias F
    Using Vedolizumab to treat Severe Sweet's Syndrome in a Patient with Ulcerative Colitis.
    J Crohns Colitis. 2018 May 19. pii: 4999769. doi: 10.1093.
    PubMed     Text format    

  50. FEAGAN BG, Bhayat F, Khalid M, Blake A, et al
    Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials.
    J Crohns Colitis. 2018 May 17. pii: 4997031. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  51. KUTSUNA R, Tomida J, Morita Y, Kawamura Y, et al
    Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis.
    PLoS One. 2018;13:e0197668.
    PubMed     Text format     Abstract available

  52. BOURGONJE AR, von Martels JZH, de Vos P, Faber KN, et al
    Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines.
    PLoS One. 2018;13:e0193202.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: